February 3, 2017 10:58 AM ESTUpdated June 28, 01:45 PM

Stemline comes clean on patient death, but questions linger; Life sciences fund launches with €100M

Shehla Shakoor

Managing Director

• Stemline $STML has been forced to admit that it received a report that one of the patients in its pivotal study of SL-401 for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Trump says he'll sign order on 'most-favored nation' drug price plans Monday

From deal to disaster: Drugmakers face a changed Washington as Trump embraces ‘most favored nation’ prices

Revolution’s KRAS drugs appear competitive in several lung cancer settings

AstraZeneca reports Phase 3 win for Imfinzi; Roche to build new manufacturing site in China

Lilly shuffles key executive positions; Mikael Dolsten takes another post-Pfizer assignment

sponsored

In one of the riskiest industries — Biotech — a surefire way to neutralize some of that risk emerges